Actively Recruiting
Evaluating a School Nurse Program to Prevent Rheumatic Heart Disease in Children Aged 5 to 16 in High-Risk Areas
Led by Thomas Pilgrim · Updated on 2026-01-20
6000
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a school-based program aimed at preventing rheumatic heart disease RHD in areas where the disease is common. This trial uses a stepped wedge cluster randomized design involving randomly selected schools in Nepal and Zambia. The goal is to see if an integrated school nurse program can reduce the occurrence of RHD among children. The intervention introduces a dedicated school nurse program that provides education about RHD, assesses and manages group A beta-hemolytic streptococcal GABHS pharyngitis, and supports secondary antibiotic prevention for children with RHD. Schools either receive this nurse program or continue with the usual care without the nurse program. The intervention is delivered at the school level. Participants aged 5 to 16 years will be monitored for the development of rheumatic heart disease for at least one year and up to three years after the school nurse program starts. Assessments include diagnosis, intervention, and follow-up of throat infections and facilitation of preventive antibiotic use. The study tracks the presence of RHD as the main outcome measure. The total duration of participation varies by each schools timing in the stepped wedge design.
CONDITIONS
Brief Title
School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions
Research Team
T
Thomas Pilgrim Bern University Hospital, Bern, Switzerland
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here